Tag: multiparametric MRI

From our perspective at the Sperling Prostate Center, the title question is somewhat absurd. I would respond with, “Who DOESN’T benefit the most from multiparametric MRI of the prostate?” The powerful 3T multiparametric MRI (mpMRI) that we offer provides... keep reading

Previously, we posted a recommended caution that men of African American descent discuss possible risks of going on Active Surveillance (AS) even when early clinical factors suggested they qualify for AS. Then, the authors of a 2018 paper noted that the observational studies encouraging more use of AS were largely composed of White men, raising the question of whether positive results of those studies should be applied to Black men. After reviewing studies that focused on Black men, they concluded... keep reading

When multiparametric MRI goes head-to-head against transrectal ultrasound (TRUS), it continues to demonstrate clear seniority in detecting clinically significant prostate cancer. Although conventional grayscale ultrasound can provide better results when combined with additional power using b-mode or Doppler USS, newer technologies continue to be developed. These include... keep reading

No doubt you are aware that many toxic substances are associated with higher cancer risk, and when there’s definite evidence of causing cancer, they are called carcinogens. For example, several national and international bodies have linked Agent Orange with prostate cancer (PCa) and numerous other cancers or cancer precursors. However, there are studies that suggest keep reading

When it comes to prostate MRI, experience matters. Discover why choosing an expert with a proven track record can make all the difference in accurate, reliable results. keep reading

Starting over a decade ago, I collaborated on research into MRI imaging features that lend themselves to Artificial Intelligence training sets for the detection/diagnosis of prostate cancer (PCa). As an early AI contributor, I’m always happy to learn how other PCa physicians integrate AI into their practice. I was delighted when CancerNetwork (home of the keep reading

Benjamin Franklin is quoted as saying nothing can be said to be certain except death and taxes. Perhaps he didn’t include aging because a) at the time of his death in 1790 the average male life expectancy was 38, or b) he led a rich and vigorous life almost till his death at age 84 keep reading

What if a scan could warn doctors about a hidden genetic threat in prostate cancer? Multiparametric MRI is revealing patterns that hint at BRCA and HRR gene mutations, offering a vital head start for targeting aggressive disease and encouraging genomic testing when it matters most. keep reading

For the right prostate cancer (PCa) patient, Active Surveillance (AS) is a good thing. Urologic professionals now see eye-to-eye on monitoring with a focus on “preventing overtreatment in patients for whom the benefit of treatment deferral outweighs the need for immediate oncologic control.”[i] That’s a technical way of saying, if you don’t have clinically significant keep reading

Prostate cancer (PCa) is considered an aging-related disease. The older a man becomes, the more likely he will develop it. It is the most common cancer in older men.[i] The Prostate Cancer Foundation says, “Although only about 1 in 456 men under age 50 will be diagnosed, the rate shoots up to 1 in 54 keep reading